Contact Points
This notice of proposed contract action is posted in accordance with FAR 5.101(a)(2). A copy of the solicitation may be obtained from the contact point.
The Therapeutic Development Branch (TDB) of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) requires exploratory studies for characterization of disease phenotype in NGY1 mutant cortical glutamatergic neurons. The contractor will undertake a series of experiments utilizing iPSCderived neurons generated from patients baring an NGY1 mutation. The goal will be to elucidate possible disease phenotypes and provide insight into the pathophysiology as it exists in cortical glutamatergic neurons. Experiments will be conducted on neurons from three NGY1 lines.
Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.
All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.